Pancreatic Cancer Research

ResearcherUNSW SydneyActive in the last 2 years

Alina Stoita

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-9460-2149; OpenAlex author ID A5057561179. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 4 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. Five-year psychological impact and surveillance compliance in the Australian Pancreatic Cancer Screening Program. Last author DOI 10.1007/s10689-026-00557-0↗
  2. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Co-author DOI 10.1038/s43018-023-00614-y↗
  3. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
  4. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Co-author DOI 10.1053/j.gastro.2021.10.014↗
  5. ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
  6. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. Last author DOI 10.1186/s13053-021-00190-1↗
  7. Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants Last author DOI 10.1186/s13053-021-00195-w↗
  8. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? First author DOI 10.3748/wjg.v27.i26.4045↗
  9. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Last author DOI 10.1007/s10689-019-00147-3↗
  10. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort. Last author DOI 10.3748/wjg.v26.i14.1660↗
  11. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Co-author DOI 10.1038/s41467-019-10968-6↗
  12. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Last author DOI 10.1186/s13053-019-0129-1↗
  13. Challenges in diagnosis of pancreatic cancer. Last author DOI 10.3748/wjg.v24.i19.2047↗
  14. Review of screening for pancreatic cancer in high risk individuals. Co-author DOI 10.3748/wjg.v17.i19.2365↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tanya M. Dwarte · 4 shared papers, 2019–2026 · strength 0.69
  2. Robert Sean O'Neill · 3 shared papers, 2020–2021 · strength 0.59
  3. Anthony James Gill · 1 shared paper, 2026 · strength 0.36
  4. Amber L. Johns · 3 shared papers, 2019–2021 · strength 0.33
  5. Krithika Murali · 2 shared papers, 2021 · strength 0.23
  6. Marios Efthymiou · 2 shared papers, 2021 · strength 0.23
  7. Mehrdad Nikfarjam · 2 shared papers, 2021 · strength 0.23
  8. Rhys Vaughan · 2 shared papers, 2021 · strength 0.23
  9. Lulu Zhang · 1 shared paper, 2018 · strength 0.14
  10. Brechtje D.M. Koopmann · 1 shared paper, 2022 · strength 0.10
  11. Jesse Lachter · 1 shared paper, 2022 · strength 0.10
  12. Ingrid C. A. W. Konings · 1 shared paper, 2022 · strength 0.10
  13. Iris J. M. Levink · 1 shared paper, 2022 · strength 0.10
  14. Marcia Irene Canto · 1 shared paper, 2022 · strength 0.10
  15. Jeanin Elise van Hooft · 1 shared paper, 2022 · strength 0.10
  16. Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.10
  17. Detlef Klaus Bartsch · 1 shared paper, 2022 · strength 0.10
  18. Marco J. Bruno · 1 shared paper, 2022 · strength 0.10
  19. Randall E. Brand · 1 shared paper, 2022 · strength 0.10
  20. Elizabeth Half · 1 shared paper, 2022 · strength 0.10
  21. Alfredo Carrato · 1 shared paper, 2022 · strength 0.10
  22. Michael Goggins · 1 shared paper, 2022 · strength 0.10
  23. Sapna Syngal · 1 shared paper, 2022 · strength 0.10
  24. Nirav C Thosani · 1 shared paper, 2022 · strength 0.10
  25. Djuna L. Cahen · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.